ALZN (Alzamend Neuro) Insider Ownership: 6.45 % (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALZN Alzamend Neuro Inc ALZN
21 GF Score
Price $1.72
! 2 Warning Signs
View Full Analysis

What is Alzamend Neuro Insider Ownership?

Alzamend Neuro ALZN +1.18% 21 Insider Ownership is 6.45 % as of Sep. 11, 2026. GuruFocus rates ALZN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alzamend Neuro's insider ownership is 6.45%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alzamend Neuro's Institutional Ownership is 63.90%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alzamend Neuro's Float Percentage Of Total Shares Outstanding is 99.44%.

Alzamend Neuro Insider Ownership Historical Data

* Premium members only.

The historical data trend for Alzamend Neuro's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzamend Neuro Insider Ownership Chart

Alzamend Neuro Historical Data

The historical data trend for Alzamend Neuro can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Insider Ownership 11.08 10.11 9.02 9.02 8.18 8.18 8.18 8.18 6.49 6.45
ALZN
21GF Score
Alzamend Neuro Inc ALZN
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzamend Neuro Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 6.45 % mean?
Alzamend Neuro (ALZN) has a Insider Ownership of 6.45 % as of Sep. 11, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Alzamend Neuro and its competitors.
Is Alzamend Neuro's Insider Ownership too high?
Alzamend Neuro's current Insider Ownership is 6.45 %. Overall, Alzamend Neuro has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Alzamend Neuro's Insider Ownership compare to CNSP and SNGX?
Alzamend Neuro's Insider Ownership of 6.45 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Alzamend Neuro and its competitors. Alzamend Neuro's current Insider Ownership is 6.45 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzamend Neuro stock overvalued right now?
Alzamend Neuro (ALZN) has a current Insider Ownership of 6.45 %. The current Insider Ownership is 6.45 %. Alzamend Neuro's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Alzamend Neuro (ALZN), the current Insider Ownership is 6.45 % as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzamend Neuro Business Description

Address 3480 Peachtree Road NE, Second Floor Suite 103, Atlanta, GA, USA, 30326
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
21GF Score

Get the complete analysis for ALZN

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.72
Price